Tags

Type your tag names separated by a space and hit enter

Atypical mycobacterium keratitis associated with penetrating keratoplasty: case report of successful therapy with topical gatifloxacin 0.3%.
Cornea. 2010 Apr; 29(4):468-70.C

Abstract

PURPOSE

To report successful therapy with gatifloxacin 0.3% ophthalmic solution (Zymar) in a patient with atypical mycobacterium keratitis after penetrating keratoplasty.

METHODS

A 58-year-old patient was referred for evaluation of microbial keratitis after penetrating keratoplasty.

RESULTS

Clinical examination of the patient revealed an infiltrate at the inferior graft-host junction with a satellite lesion with a mild inflammatory reaction in the anterior chamber. Microbiologic evaluation confirmed the diagnosis of atypical mycobacteria keratitis. The corneal abscess was completely eradicated with a topical course of gatifloxacin 0.3% with preservation of graft clarity and good visual acuity. Topical treatment with gatifloxacin 0.3% was continued for an additional period of 5 months.

CONCLUSION

Topical gatifloxacin 0.3% may be successfully used to treat microbial keratitis resulting from atypical mycobacteria.

Authors+Show Affiliations

Cornea & Refractive Service, Asociación para Evitar la Ceguera en México, Hospital Dr. Luis Sánchez Bulnes, Vicente Garcia Torres, 46 San Lucas Coyoacan, Mexico City, Mexico. albalbuena@prodigy.net.mxNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

20164758

Citation

Perez-Balbuena, Ana Lilia, et al. "Atypical Mycobacterium Keratitis Associated With Penetrating Keratoplasty: Case Report of Successful Therapy With Topical Gatifloxacin 0.3%." Cornea, vol. 29, no. 4, 2010, pp. 468-70.
Perez-Balbuena AL, Vanzzini-Zago V, Garza M, et al. Atypical mycobacterium keratitis associated with penetrating keratoplasty: case report of successful therapy with topical gatifloxacin 0.3%. Cornea. 2010;29(4):468-70.
Perez-Balbuena, A. L., Vanzzini-Zago, V., Garza, M., & Cancino, D. C. (2010). Atypical mycobacterium keratitis associated with penetrating keratoplasty: case report of successful therapy with topical gatifloxacin 0.3%. Cornea, 29(4), 468-70. https://doi.org/10.1097/ICO.0b013e3181b532c7
Perez-Balbuena AL, et al. Atypical Mycobacterium Keratitis Associated With Penetrating Keratoplasty: Case Report of Successful Therapy With Topical Gatifloxacin 0.3%. Cornea. 2010;29(4):468-70. PubMed PMID: 20164758.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Atypical mycobacterium keratitis associated with penetrating keratoplasty: case report of successful therapy with topical gatifloxacin 0.3%. AU - Perez-Balbuena,Ana Lilia, AU - Vanzzini-Zago,Virginia, AU - Garza,Manuel, AU - Cancino,Diego Cuevas, PY - 2010/2/19/entrez PY - 2010/2/19/pubmed PY - 2011/1/28/medline SP - 468 EP - 70 JF - Cornea JO - Cornea VL - 29 IS - 4 N2 - PURPOSE: To report successful therapy with gatifloxacin 0.3% ophthalmic solution (Zymar) in a patient with atypical mycobacterium keratitis after penetrating keratoplasty. METHODS: A 58-year-old patient was referred for evaluation of microbial keratitis after penetrating keratoplasty. RESULTS: Clinical examination of the patient revealed an infiltrate at the inferior graft-host junction with a satellite lesion with a mild inflammatory reaction in the anterior chamber. Microbiologic evaluation confirmed the diagnosis of atypical mycobacteria keratitis. The corneal abscess was completely eradicated with a topical course of gatifloxacin 0.3% with preservation of graft clarity and good visual acuity. Topical treatment with gatifloxacin 0.3% was continued for an additional period of 5 months. CONCLUSION: Topical gatifloxacin 0.3% may be successfully used to treat microbial keratitis resulting from atypical mycobacteria. SN - 1536-4798 UR - https://www.unboundmedicine.com/medline/citation/20164758/Atypical_mycobacterium_keratitis_associated_with_penetrating_keratoplasty:_case_report_of_successful_therapy_with_topical_gatifloxacin_0_3_ L2 - http://dx.doi.org/10.1097/ICO.0b013e3181b532c7 DB - PRIME DP - Unbound Medicine ER -